Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2000Acute coronary findings at autopsy in heart failure patients with sudden death : results from the assessment of treatment with lisinopril and survival (ATLAS) trialUretsky, B.; Thygesen, K.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.; Ryden, L.
2001Cardiovascular critical event pathways for the progression of heart failure; A report from the ATLAS studyCleland, J.; Thygesen, K.; Uretsky, B.; Armstrong, P.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.; Ryden, L.
2005Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia - A pharmacokinetic and pharmacodynamic investigationCleland, J.; Sullivan, J.; Ball, S.; Horowitz, J.; Agoram, B.; Rosser, D.; Yates, W.; Tin, L.; Fuentealba, P.; Burton, P.
2000Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitusRyden, L.; Armstrong, P.; Cleland, J.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.
2000Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) StudySculpher, M.; Poole, L.; Cleland, J.; Drummond, M.; Armstrong, P.; Horowitz, J.; Massie, B.; Poole-Wilson, P.; Ryden, L.
2001Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trialMassie, B.; Armstrong, P.; Cleland, J.; Horowitz, J.; Packer, M.; Poole-Wilson, P.; Ryden, L.